Artificial intelligence in critically ill diabetic patients: current status and future prospects

Table 4 Continuous glucose monitoring devices

Type of device	Name of device	Comments
Intravenous	GlucoClear by Edwards Lifesciences; (Irvine, CA)	Approved in Europe
Intravenous	Glysure System by Glysure (Abingdon, UK)	Approved in Europe
Intravenous	Eirus by Maquet Getinge Group (Rastatt, Germany)	Approved in Europe
Intravenous	OptiScanner 5000 by OptiScan; (Hayward, CA)	Approved in EuropeFDA-approved for use in US hospitals
Intravenous	GlucoScout (International Biomedical, Austin, TX)	FDA-approved for use in US hospitals
Intravenous	Dexcom G	FDA-approved and CEA approved
Intravenous	Guardian™ Connect system by Medtronic (San Diego, CA)	FDA-approved for use in US hospitals
Subcutaneous	Freestyle Libre by Abbott Diabetes Care	US FDA approved

FDA: Food and Drug Administration; CEA: Carcinoembryonic antigen.